SAM
CNCE

Senzar Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Senzar Asset Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-29,821
Closed -$502K – 19
2018
Q2 		$502K Sell
29,821
-169,318
-85% -$3.29M 1.45% 18
2018
Q1 		$4.56M Sell
199,139
-77,206
-28% -$1.72M 1.44% 27
2017
Q4 		$7.15M Sell
276,345
-59,100
-18% -$1.19M 1.83% 21
2017
Q3 		$4.95M Sell
335,445
-76,700
-19% -$1.11M 1.21% 22
2017
Q2 		$5.75M Sell
412,145
-4,700
-1% -$69.3K 1.42% 18
2017
Q1 		$7.11M Buy
416,845
+16,257
+4% +$195K 1.8% 20
2016
Q4 		$4.12M Sell
400,588
-171,800
-30% -$1.57M 1.09% 22
2016
Q3 		$5.79M Sell
572,388
-228,400
-29% -$2.5M 1.5% 22
2016
Q2 		$8.99M Sell
800,788
-670,905
-46% -$8.54M 1.96% 16
2016
Q1 		$20.1M Buy
1,471,693
+39,076
+3% +$562K 3.99% 9
2015
Q4 		$27.2M Sell
1,432,617
-213,056
-13% -$4.63M 3.02% 9
2015
Q3 		$30.9M Buy
1,645,673
+88,139
+6% +$1.5M 4.49% 6
2015
Q2 		$23.2M Buy
1,557,534
+441,434
+40% +$6.72M 3.98% 6
2015
Q1 		$16.9M Buy
1,116,100
+249,900
+29% +$3.49M 4.12% 9
2014
Q4 		$11.5M Buy
866,200
+605,000
+232% +$7.81M 3.38% 10
2014
Q3 		$3.29M Buy
+261,200
New +$2.53M 0.97% 25

Other funds holding CNCE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Senzar Asset Management's CNCE Position: Q3 2018 in Review

Senzar Asset Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2018, closing a stake of 29,821 shares — an estimated $502K sold.

Senzar Asset Management first reported a position in CNCE in Q3 2014 and held it in 16 quarters. The position peaked at $30.9M in Q3 2015. 111 funds tracked by Wall St. Rank hold CNCE as of Q3 2018.

  • Senzar Asset Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Senzar Asset Management sold 29,821 Concert Pharmaceuticals, Inc. shares in Q3 2018, an estimated $502K.
  • Senzar Asset Management first reported a position in Concert Pharmaceuticals, Inc. in Q3 2014 and held it in 16 quarters.
  • Senzar Asset Management's Concert Pharmaceuticals, Inc. position peaked at $30.9M in Q3 2015.
  • 111 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.